Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway. Vlaming M, Bleiker EMA, Schijven G, Kiemeney LALM, et al. Int J Cancer 2025 Oct 13. doi: 10.1002/ijc.70194.

Read + Share

Amedeo Smart

Independent Medical Education

Vlaming M, Bleiker EMA, Schijven G, Kiemeney LALM, et al. Experiences of metastatic prostate cancer patients with a mainstream genetic testing pathway. Int J Cancer 2025 Oct 13. doi: 10.1002/ijc.70194.
PMID: 41078342